0.27
+0.011663(+4.43%)
Currency In USD
| Previous Close | 0.26 |
| Open | 0.26 |
| Day High | 0.28 |
| Day Low | 0.25 |
| 52-Week High | 0.83 |
| 52-Week Low | 0.2 |
| Volume | 55,399 |
| Average Volume | 72,709 |
| Market Cap | 7.82M |
| PE | -1.72 |
| EPS | -0.16 |
| Moving Average 50 Days | 0.31 |
| Moving Average 200 Days | 0.47 |
| Change | 0.01 |
If you invested $1000 in Biotricity, Inc. (BTCY) since IPO date, it would be worth $11.23 as of February 21, 2026 at a share price of $0.275. Whereas If you bought $1000 worth of Biotricity, Inc. (BTCY) shares 5 years ago, it would be worth $24.12 as of February 21, 2026 at a share price of $0.275.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
GlobeNewswire Inc.
Feb 11, 2026 9:00 PM GMT
REDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to transforming chronic condition detection and management with state-o
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
GlobeNewswire Inc.
Feb 05, 2026 9:15 PM GMT
Company continues to drive Revenue Growth, Margin Strength, Operational Efficiency, and continued positive EBITDA REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) com
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
GlobeNewswire Inc.
Nov 14, 2025 9:00 PM GMT
REDWOOD CITY, CA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-th